Publications by authors named "Juyeon Choi"

Anion exchange membrane (AEM) water electrolysis (AEMWE) is considered an economical technology for producing green hydrogen energy. However, conventional AEMs comprising polymer backbones with anisotropically aligned cationic pendant groups exhibit unsatisfactory AEMWE performance and durability, limiting their practical implementation. Herein, a facile method for fabricating a durable high-performance AEM via a one-pot monomer-level Menshutkin (m-Men) reaction in a porous mechanical support is proposed.

View Article and Find Full Text PDF

Anion-exchange membranes (AEMs) are the key components of AEM-based water electrolysis (AEMWE) for green hydrogen production. Unfortunately, many AEMs have unsatisfactory ion conductivity, and the factors governing their ion transport remain unclear. To address these limitations, herein, a new pyrrolidinium-containing diallylammonium-cyclopolymerized (PDT) AEM is proposed.

View Article and Find Full Text PDF

Global interest in the recycling of precious metals (PMs) in various industrial sectors has spurred the exploration of high-performance PM adsorbents. Unfortunately, many adsorbents exhibit unsatisfactory PM adsorption performance and require complex fabrication protocols and toxic chemicals. Hence, further development of simple, efficient, and eco-friendly adsorbents is necessary.

View Article and Find Full Text PDF

Background: Encouraging annual updated COVID-19 vaccinations for high-risk populations is crucial for public health. However, concerns about significant reactogenicity persist, contributing to vaccine hesitancy. To investigate evolving COVID-19 vaccine reactogenicity and immunogenicity, we conducted a longitudinal analysis across three COVID-19 vaccine cohorts.

View Article and Find Full Text PDF

The most critical aspect of managing methicillin-resistant S. aureus (MRSA) infections is preventing their spread by directly controlling MRSA. Studies have revealed that light-emitting diodes (LEDs) or lasers can be used for photodynamic therapy (PDT) to effectively kill MRSA.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how immunity to COVID-19 has evolved from the pandemic to endemic phases, focusing on the updated XBB.1.5 monovalent vaccine (MonoV).
  • Researchers tracked 327 healthcare workers over three years, assessing various immunity responses through blood samples collected at different times.
  • Findings reveal that while antibody levels declined initially, they were maintained and even enhanced in the endemic phase, with the MonoV showing significantly improved neutralization against new virus strains compared to previous vaccines.
View Article and Find Full Text PDF

High-performance and durable anion exchange membranes (AEMs) are critical for realizing economical green hydrogen production through alkaline water electrolysis (AWE) or AEM water electrosysis (AEMWE). However, existing AEMs require sophisticated fabrication protocols and exhibit unsatisfactory electrochemical performance and long-term durability. Here we report an AEM fabricated via a one-pot, in situ interfacial Menshutkin reaction, which assembles a highly cross-linked polymer containing high-density quaternary ammoniums and nanovoids inside a reinforcing porous support.

View Article and Find Full Text PDF

Background/aim: Epithelial ovarian cancer (EOC) is a lethal disease that is the fifth leading cause of cancer-related death in women. BAF312 (siponimod) is a potent and selective sphingosine-1-phosphate (S1P) receptor modulator that has been approved as a treatment for multiple sclerosis. In addition to its immunomodulatory action, BAF312 shows preclinical antitumor effects in several cancer types.

View Article and Find Full Text PDF
Article Synopsis
  • Chemoresistant-epithelial ovarian cancer (EOC) has a poor prognosis, prompting researchers to explore new treatments, particularly the anticancer potential of certain antipsychotic drugs from the diphenylbutylpiperidine (DPBP) class.
  • In vitro studies with various EOC cell lines and in vivo models showed that DPBP drugs, especially penfluridol, significantly reduced cell proliferation and increased apoptosis in both chemosensitive and chemoresistant cells.
  • The research demonstrated that penfluridol not only effectively reduced tumor weight in xenografts but also worked against paclitaxel-resistant models, suggesting its potential as a promising therapeutic option for EOC treatment.
View Article and Find Full Text PDF

Purpose: Ovarian cancer has the highest mortality rate and lowest survival rate among female reproductive system malignancies. There are treatment options of surgery and chemotherapy, but both are limited. In this study, we developed and evaluated micelles composed of D-α-tocopheryl polyethylene-glycol (PEG) 1000 succinate (TPGS) and Soluplus (SOL) loaded with olaparib (OLA), a poly(ADP-ribose)polymerase (PARP) inhibitor, and rapamycin (RAPA), a mammalian target of rapamycin (mTOR) inhibitor in ovarian cancer.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examined the durability of immunity following the third dose of COVID-19 vaccines in 94 healthy adults, finding that antibody levels remained significantly higher even 9-12 months later compared to levels after the second dose.
  • - Anti-spike IgG antibody responses peaked after the third dose but gradually decreased over time; however, breakthrough infections during the Omicron period increased neutralizing antibodies against various strains.
  • - The results suggest that the mRNA vaccine booster leads to lasting humoral immunity for at least a year and maintains T-cell immunity, indicating the potential for an annual COVID-19 vaccination approach.
View Article and Find Full Text PDF

Background: The FGF/FGFR signaling pathway plays a critical role in human cancers. We analyzed the anti-tumor effect of AZD4547, an inhibitor targeting the FGF/FGFR pathway, in epithelial ovarian cancer (EOC) and strategies on overcoming AZD4547 resistance.

Methods: The effect of AZD4547 on cell viability/migration was evaluated and in vivo experiments in intraperitoneal xenografts using EOC cells and a patient-derived xenograft (PDX) model were performed.

View Article and Find Full Text PDF

Despite a high vaccination rate, the COVID-19 pandemic continues with immune-evading Omicron variants. The success of additional antigenic stimulation through breakthrough infection (BI) and updated vaccination in overcoming antigenic imprinting needs to be determined. Participants in a long-term follow-up cohort of healthcare worker (HCW) vaccinee were categorized according to their infection/vaccination status.

View Article and Find Full Text PDF

Ulipristal acetate (UPA) is a selective progesterone receptor modulator and is used for the treatment of uterine leiomyoma (a benign tumor). Uterine sarcoma which is highly malignant cancer with a poor prognosis is clinically resembled with uterine leiomyoma. There has been no experimental research on the effect of UPA on uterine sarcoma.

View Article and Find Full Text PDF

The coronavirus disease 2019 pandemic persisted for 3 years and is now transitioning to endemicity. We illustrated the change in group immunity induced by vaccination (monovalent vaccines) and breakthrough infections (BIs) in a healthcare worker (HCW) cohort. Five sampling points were analyzed: before the third dose and 1, 3, 5, and 8 months after the vaccination.

View Article and Find Full Text PDF

Maxim (SMM) is a Korean endemic plant belonging to the Crassulaceae family. This study aimed to investigate the antitumor effects of the SMM extract on human ovarian cancer cells. Among five endemic plants grown in Korea, the SMM extract showed the most potent cytotoxicity in ovarian cancer cells and had little effect on normal ovarian surface epithelial cells.

View Article and Find Full Text PDF

Alkaline water electrolysis (AWE) is considered a promising technology for green hydrogen (H ) production. Conventional diaphragm-type porous membranes have a high risk of explosion owing to their high gas crossover, while nonporous anion exchange membranes lack mechanical and thermochemical stability, limiting their practical application. Herein, a thin film composite (TFC) membrane is proposed as a new category of AWE membranes.

View Article and Find Full Text PDF
Article Synopsis
  • Fenbendazole (FZ) shows promise as an anti-cancer treatment for epithelial ovarian cancer (EOC), but its effectiveness is hindered due to poor water solubility.
  • The study compared different drug delivery methods for FZ, including oral and intraperitoneal administration, as well as the use of FZ-encapsulated PLGA nanoparticles (FZ-PLGA-NPs) to enhance absorption and efficacy.
  • Results indicate that FZ-PLGA-NPs significantly reduced cell proliferation in both in vitro EOC cell lines and in vivo models, demonstrating their potential as a more effective delivery method for cancer therapy and necessitating further clinical trials.
View Article and Find Full Text PDF

Purpose: We aimed to inhibit ovarian cancer (OC) development by interfering with microtubule polymerization and inhibiting mTOR signaling. To achieve this, previously developed micelles containing fenbendazole and rapamycin were applied.

Methods: Herein, we prepared micelles for drug delivery using fenbendazole and rapamycin at a 1:2 molar ratio and methoxy poly(ethylene glycol)--poly(caprolactone)(mPEG--PCL) via freeze-drying.

View Article and Find Full Text PDF

Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the persistence of the pandemic, even with mass coronavirus disease 2019 (COVID-19) vaccination, have raised questions about the durability of immunity and extent of cross-reactive immunity after vaccination. This study aimed to characterize the humoral and cellular immune response to the mRNA-1273 vaccine using a prospective longitudinal cohort.

Methods: We recruited 177 young SARS-CoV-2 infection-naive adults.

View Article and Find Full Text PDF

Messenger RNA (mRNA) vaccination was developed to mitigate the coronavirus disease 2019 pandemic. However, data on antibody kinetics and factors influencing these vaccines' immunogenicity are limited. We conducted a prospective study on healthy young adults who received two doses of the mRNA-1273 vaccine at 28-day intervals.

View Article and Find Full Text PDF

Introduction: Despite vaccine development, the COVID-19 pandemic is ongoing due to immunity-escaping variants of concern (VOCs). Estimations of vaccine-induced protective immunity against VOCs are essential for setting proper COVID-19 vaccination policy.

Methods: We performed plaque-reduction neutralizing tests (PRNTs) using sera from healthcare workers (HCWs) collected from baseline to six months after COVID-19 vaccination and from convalescent COVID-19 patients.

View Article and Find Full Text PDF

Evaluation of the safety and immunogenicity of new vaccine platforms is needed to increase public acceptance of coronavirus disease 2019 (COVID-19) vaccines. Here, we evaluated the association between reactogenicity and immunogenicity in healthy adults following vaccination by analyzing blood samples before and after sequential two-dose vaccinations of BNT162b2 and ChAdOx1 nCoV-19. Outcomes included anti-S IgG antibody and neutralizing antibody responses, adverse events, and proinflammatory cytokine responses.

View Article and Find Full Text PDF